NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. Show more

455 North Bernardo Avenue, Mountain View, CA, 94043, United States

Medical Devices
Healthcare
Start AI Chat

Market Cap

485M

52 Wk Range

$7.56 - $18.98

Previous Close

$14.56

Open

$14.57

Volume

99,173

Day Range

$14.48 - $14.80

Enterprise Value

354.4M

Cash

60.01M

Avg Qtr Burn

-1.944M

Insider Ownership

2.72%

Institutional Own.

96.68%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date